Dalton Investments’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-205,900
| Closed | -$3.09M | – | 22 |
|
|
2025
Q2 | $3.09M | Hold |
205,900
| – | – | 1.64% | 9 |
|
|
2025
Q1 | $2.72M | Hold |
205,900
| – | – | 1.46% | 12 |
|
|
2024
Q4 | $3.25M | Sell |
205,900
-62,600
| -23% | -$940K | 1.69% | 13 |
|
|
2024
Q3 | $4.27M | Hold |
268,500
| – | – | 2.52% | 10 |
|
|
2024
Q2 | $4.09M | Hold |
268,500
| – | – | 2.33% | 9 |
|
|
2024
Q1 | $3.94M | Hold |
268,500
| – | – | 2.39% | 9 |
|
|
2023
Q4 | $3.74M | Hold |
268,500
| – | – | 2.47% | 10 |
|
|
2023
Q3 | $3.59M | Hold |
268,500
| – | – | 2.78% | 8 |
|
|
2023
Q2 | $3.39M | Hold |
268,500
| – | – | 2.87% | 8 |
|
|
2023
Q1 | $3.06M | Hold |
268,500
| – | – | 2.68% | 7 |
|
|
2022
Q4 | $2.78M | Hold |
268,500
| – | – | 2.4% | 7 |
|
|
2022
Q3 | $2.81M | Hold |
268,500
| – | – | 2.31% | 7 |
|
|
2022
Q2 | $2.97M | Hold |
268,500
| – | – | 2.71% | 7 |
|
|
2022
Q1 | $2.99M | Hold |
268,500
| – | – | 2.11% | 9 |
|
|
2021
Q4 | $3.51M | Hold |
268,500
| – | – | 2.29% | 9 |
|
|
2021
Q3 | $3.5M | Hold |
268,500
| – | – | 2.56% | 9 |
|
|
2021
Q2 | $3.95M | Hold |
268,500
| – | – | 2.17% | 14 |
|
|
2021
Q1 | $3.3M | Hold |
268,500
| – | – | 1.81% | 15 |
|
|
2020
Q4 | $3.83M | Hold |
268,500
| – | – | 1.89% | 14 |
|
|
2020
Q3 | $3.73M | Sell |
268,500
-110,000
| -29% | -$1.31M | 2.46% | 15 |
|
|
2020
Q2 | $4.01M | Hold |
378,500
| – | – | 2.92% | 12 |
|
|
2020
Q1 | $3.05M | Hold |
378,500
| – | – | 2.36% | 14 |
|
|
2019
Q4 | $3.07M | Sell |
378,500
-398,500
| -51% | -$3.15M | 1.89% | 17 |
|
|
2019
Q3 | $5.89M | Sell |
777,000
-307,500
| -28% | -$2.29M | 3.72% | 7 |
|
|
2019
Q2 | $8.13M | Sell |
1,084,500
-109,500
| -9% | -$861K | 3.69% | 9 |
|
|
2019
Q1 | $9.67M | Buy |
1,194,000
+239,000
| +25% | +$1.82M | 4.22% | 8 |
|
|
2018
Q4 | $7.2M | Sell |
955,000
-12,000
| -1% | -$84.4K | 3.87% | 9 |
|
|
2018
Q3 | $6.69M | Buy |
967,000
+178,000
| +23% | +$1.19M | 3.14% | 11 |
|
|
2018
Q2 | $5.08M | Hold |
789,000
| – | – | 2.18% | 13 |
|
|
2018
Q1 | $5.16M | Sell |
789,000
-356,000
| -31% | -$2.49M | 2.15% | 13 |
|
|
2017
Q4 | $8.6M | Buy |
1,145,000
+110,000
| +11% | +$792K | 3.24% | 10 |
|
|
2017
Q3 | $7.39M | Hold |
1,035,000
| – | – | 3.3% | 10 |
|
|
2017
Q2 | $8.72M | Buy |
1,035,000
+144,000
| +16% | +$1.17M | 3.28% | 11 |
|
|
2017
Q1 | $7.16M | Buy |
891,000
+621,000
| +230% | +$5.36M | 2.97% | 14 |
|
|
2016
Q4 | $2.44M | Buy |
270,000
+12,000
| +5% | +$112K | 1.17% | 19 |
|
|
2016
Q3 | $2.4M | Buy |
+258,000
| New | +$2.46M | 0.97% | 16 |
|
Other funds holding RDY
AIM
Dalton Investments's RDY Position: Q3 2025 in Review
Dalton Investments sold out of Dr. Reddy's Laboratories (RDY) in Q3 2025, closing a stake of 205,900 shares — an estimated $3.09M sold.
Dalton Investments first reported a position in RDY in Q3 2016 and held it in 36 quarters. The position peaked at $9.67M in Q1 2019. 228 funds tracked by Wall St. Rank hold RDY as of Q3 2025.
- Dalton Investments reported no remaining Dr. Reddy's Laboratories position as of Q3 2025 after selling out during the quarter.
- Dalton Investments sold 205,900 Dr. Reddy's Laboratories shares in Q3 2025, an estimated $3.09M.
- Dalton Investments first reported a position in Dr. Reddy's Laboratories in Q3 2016 and held it in 36 quarters.
- Dalton Investments's Dr. Reddy's Laboratories position peaked at $9.67M in Q1 2019.
- 228 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2025.
Based on Dalton Investments's 13F filing for Q3 2025, filed 6 Nov 2025.